Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic options in neuromyelitis optica spectrum disorders.
Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
Combined central and peripheral demyelination.
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
Uptake and presentation of myelin basic protein by normal human B cells.
[Clinical features of 314 patients with relapsing-remitting multiple sclerosis].
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent.
Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.
Sleep disorders in multiple sclerosis and their relationship to fatigue.
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.
Cerebral tumefactive demyelinating lesions.
miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
Causes of death among persons with multiple sclerosis.
Correction to: The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Myelin basic protein induces neuron-specific toxicity by directly damaging the neuronal plasma membrane.
Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.
Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.

Pages